The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AR enhancer and locus genomic alterations as cell-free DNA biomarkers of primary resistance to AR-directed treatment of metastatic prostate cancer.
 
Chris Maher
Leadership - Prostate Management Diagnostics, Inc.
 
Ha X. Dang
No Relationships to Disclose
 
Pradeep S. Chauhan
No Relationships to Disclose
 
Haley Ellis
No Relationships to Disclose
 
Wenjia Feng
No Relationships to Disclose
 
Peter Harris
No Relationships to Disclose
 
Grace Smith
No Relationships to Disclose
 
Mark Qiao
No Relationships to Disclose
 
Katherine Dienstbach
No Relationships to Disclose
 
Rachel Beck
No Relationships to Disclose
 
Andrew Atkocius
No Relationships to Disclose
 
Faridi Qaium
Stock and Other Ownership Interests - Centene
 
Jingqin Luo
No Relationships to Disclose
 
Jeff Michalski
No Relationships to Disclose
 
Joel Picus
Consulting or Advisory Role - Novo Nordisk; Sanofi
Research Funding - Agensys (Inst); BioClin Therapeutics (Inst); BioClin Therapeutics (Inst); eFFECTOR Therapeutics (Inst); Endocyte (Inst); Innocrin Pharma (Inst); Mirati Therapeutics (Inst); Rexahn Pharmaceuticals (Inst); Seagen (Inst); TRACON Pharma (Inst)
 
Russell Kent Pachynski
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Dendreon; EMD Serono; Genomic Health; Jounce Therapeutics; Pfizer/EMD Serono; Sanofi
Speakers' Bureau - AstraZeneca; Dendreon; Genentech/Roche; Genomic Health; Merck; Sanofi
Research Funding - Janssen Oncology
Travel, Accommodations, Expenses - Genentech/Roche
 
Aadel Chaudhuri
Stock and Other Ownership Interests - Geneoscopy
Honoraria - Foundation Medicine; Roche
Consulting or Advisory Role - Fenix Group International; Geneoscopy; Roche; Tempus
Patents, Royalties, Other Intellectual Property - US Patent No. US 8,685,727 B2, Licensed to Biocognitive Labs in May 2019.
Travel, Accommodations, Expenses - Foundation Medicine; Roche
Other Relationship - Roche